Proscia: Top clinical teaching hospital is laying the foundation for AI-driven disease diagnosis and research HAARLEM, Netherlands and PHILADELPHIA – October 27, 2025 – Spaarne Gasthuis, a top clinical teaching hospital serving part of...

Proscia: Expanding the industry’s most comprehensive portfolio of AI applications  PHILADELPHIA and PARIS—October 15, 2025—Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to...

The Future of Precision Medicine Starts at the Moment of Diagnosis OCTOBER 28, 2025 | 11:30AM ET | VIRTUAL EVENT Join Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision...

Proscia: Pathologists readily embrace the shift to digital workflows LEXINGTON, KY and PHILADELPHIA, PA – September 30, 2025  – Pathology & Cytology Laboratories (P&C Labs), a nationally recognized leader in pathology...

Proscia: Delivering a menu of H&E, IHC, and special stains on the Concentriq platform PHILADELPHIA and LOS ANGELES – September 24, 2025 – Proscia®, a pathology AI company, is introducing virtual staining in...

The latest from the Proscia blog Unlocking a Critical Use Case in Pathology Cytology has always been one of the most technically demanding areas of pathology. Unlike histology, where tissue sections are relatively uniform, cytology samples...